Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL

This publication has 59 references indexed in Scilit:

• Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice
  Published by Elsevier ,2002
• Transcytosis of Lipoprotein Lipase across Cultured Endothelial Cells Requires Both Heparan Sulfate Proteoglycans and the Very Low Density Lipoprotein Receptor
  Journal of Biological Chemistry, 2001
• Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.
  Journal of Clinical Investigation, 1998
• Correction of Hypertriglyceridemia and Impaired Fat Tolerance in Lipoprotein Lipase–Deficient Mice by Adenovirus-Mediated Expression of Human Lipoprotein Lipase
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium.
  Journal of Clinical Investigation, 1996
• Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
  Journal of Clinical Investigation, 1995
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
  Published by Elsevier ,1992
• Rapid and simple isolation procedure for lipoprotein lipase from human milk
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Effect of serum and C‐apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase
  FEBS Letters, 1976
• Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
  Biochemical and Biophysical Research Communications, 1972